End-of-day quote
Pakistan S.E.
23:00:00 27/06/2024 BST
|
5-day change
|
1st Jan Change
|
13.1
PKR
|
-.--%
|
|
-4.10%
|
+4.80%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,324
|
4,602
|
9,780
|
6,499
|
1,620
|
2,132
|
Enterprise Value (EV)
1 |
1,511
|
3,009
|
8,452
|
5,741
|
1,479
|
1,820
|
P/E ratio
|
-35.1
x
|
-21
x
|
-102
x
|
-18.6
x
|
38.6
x
|
14.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.58
x
|
0.73
x
|
1.24
x
|
0.8
x
|
0.22
x
|
0.2
x
|
EV / Revenue
|
0.26
x
|
0.48
x
|
1.07
x
|
0.7
x
|
0.2
x
|
0.17
x
|
EV / EBITDA
|
-17.1
x
|
-13.9
x
|
-97.9
x
|
-13.4
x
|
16.5
x
|
7.37
x
|
EV / FCF
|
-2.14
x
|
-4.31
x
|
10.7
x
|
-14.5
x
|
-17.9
x
|
14
x
|
FCF Yield
|
-46.8%
|
-23.2%
|
9.36%
|
-6.91%
|
-5.58%
|
7.15%
|
Price to Book
|
2.46
x
|
2.05
x
|
4.58
x
|
3.73
x
|
0.93
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
70,567
|
170,567
|
170,567
|
170,567
|
170,567
|
170,567
|
Reference price
2 |
47.10
|
26.98
|
57.34
|
38.10
|
9.500
|
12.50
|
Announcement Date
|
05/04/19
|
30/04/20
|
06/04/21
|
06/04/22
|
06/04/23
|
02/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,730
|
6,294
|
7,881
|
8,158
|
7,496
|
10,765
|
EBITDA
1 |
-88.12
|
-215.8
|
-86.34
|
-429.5
|
89.8
|
246.9
|
EBIT
1 |
-131.8
|
-248.9
|
-125.6
|
-471.1
|
51.69
|
214.2
|
Operating Margin
|
-2.3%
|
-3.96%
|
-1.59%
|
-5.77%
|
0.69%
|
1.99%
|
Earnings before Tax (EBT)
1 |
-134.1
|
-245.8
|
-136
|
-492.2
|
60.17
|
224.9
|
Net income
1 |
-94.7
|
-176.7
|
-95.72
|
-349.2
|
42.03
|
142.7
|
Net margin
|
-1.65%
|
-2.81%
|
-1.21%
|
-4.28%
|
0.56%
|
1.33%
|
EPS
2 |
-1.342
|
-1.288
|
-0.5612
|
-2.047
|
0.2464
|
0.8366
|
Free Cash Flow
1 |
-706.2
|
-698.5
|
790.9
|
-397
|
-82.51
|
130.2
|
FCF margin
|
-12.33%
|
-11.1%
|
10.04%
|
-4.87%
|
-1.1%
|
1.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
52.73%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
91.23%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/04/19
|
30/04/20
|
06/04/21
|
06/04/22
|
06/04/23
|
02/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,813
|
1,593
|
1,329
|
758
|
142
|
312
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-706
|
-699
|
791
|
-397
|
-82.5
|
130
|
ROE (net income / shareholders' equity)
|
-6.54%
|
-9.83%
|
-4.37%
|
-18%
|
2.41%
|
7.74%
|
ROA (Net income/ Total Assets)
|
-0.43%
|
-0.8%
|
-0.37%
|
-1.34%
|
0.15%
|
0.56%
|
Assets
1 |
22,236
|
22,032
|
25,622
|
26,037
|
28,304
|
25,656
|
Book Value Per Share
2 |
19.20
|
13.10
|
12.50
|
10.20
|
10.20
|
11.40
|
Cash Flow per Share
2 |
26.00
|
9.630
|
8.590
|
5.290
|
1.280
|
2.010
|
Capex
1 |
395
|
579
|
233
|
139
|
32.8
|
130
|
Capex / Sales
|
6.9%
|
9.2%
|
2.96%
|
1.7%
|
0.44%
|
1.21%
|
Announcement Date
|
05/04/19
|
30/04/20
|
06/04/21
|
06/04/22
|
06/04/23
|
02/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +4.80% | 8.03M | | +8.25% | 50.75B | | +6.14% | 49.91B | | +24.42% | 47.64B | | +13.00% | 42.08B | | +21.91% | 38.54B | | +17.16% | 33.02B | | -2.39% | 28.42B | | -9.01% | 27.19B | | +28.96% | 26.64B |
Other Life & Health Insurance
|